Home > Riviste > La Rivista Italiana della Medicina di Laboratorio > Fascicoli precedenti > La Rivista Italiana della Medicina di Laboratorio 2022 Giugno;18(2) > La Rivista Italiana della Medicina di Laboratorio 2022 Giugno;18(2):85-90

ULTIMO FASCICOLO
 

JOURNAL TOOLS

Opzioni di pubblicazione
eTOC
Per abbonarsi
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

ARTICOLO ORIGINALE   

La Rivista Italiana della Medicina di Laboratorio 2022 Giugno;18(2):85-90

DOI: 10.23736/S1825-859X.22.00143-8

Copyright © 2022 EDIZIONI MINERVA MEDICA

lingua: Inglese

The impact of COVID-19 on some aspects of laboratory activities

Recai ACI 1 , Adem KESKIN 2

1 Department of Biochemistry, Samsun Training and Research Hospital, Health Sciences University, Samsun, Turkey; 2 Department of Medicine Biochemistry, Institute of Health Sciences, Aydin Adnan Menderes University, Aydin, Turkey



BACKGROUND: The COVID-19 outbreak has affected the activities of many fields. This study aimed to evaluate the impact of the COVID-19 outbreak on laboratory activity.
METHODS: The data of the study were obtained from a single-center homogeneous group in the biochemistry laboratory of Samsun Training and Research Hospital. These data were divided into two patient groups: Group A (Pre-COVID-19 outbreak period patients) and Group B (COVID-19 outbreak period patients). Erythrocyte sedimentation rate (ESR), hormones, coagulation, glycosylated hemoglobin, biochemistry, complete blood count (CBC), blood gas, urine sample types, and pre-analytical errors were included. The data of the two groups were compared with the chi-square test.
RESULTS: The number of samples requested per patient was 0.62 in Group A and 0.67 in Group B. The reduction rate detected in biochemistry (P<0.001), blood gas (P<0.001) and CBC (P=0.007) sample types was lower than the reduction rate detected in the number of patients in Group B. On the other hand, the reduction rate detected in ESR (P<0.001), coagulation (P=0.045), glycosylated hemoglobin (P<0.001), and urine (P<0.001) sample types was higher than the reduction rate detected in the number of patients in Group B. The pre-analytical error rate in Group B (0.46%) was higher than in Group A (0.29%) (P<0.001). The rate of hemolyzed samples was higher, and the rate of the incorrect request was lower in Group B.
CONCLUSIONS: Laboratory test requests per patient and pre-analytical error rates increased significantly during the COVID-19 outbreak.


KEY WORDS: Pandemics; COVID-19; Laboratories. Pre-analytical error

inizio pagina